Partnership and licensing opportunities from Ab Studio Inc.
Three patented novel technology platforms: Partnership CAAD for regular therapeutic antibody design: ServiceApply Ab Studio’s unique methodology to screen hybridoma clones secreting cancer-specifc internalization antibodies or phages displaying internalization antibodies
Apply “knob into hole” and common light chain technologies for bispecific antibody development
Use Ab Studio’s unique methodology to screen common light chains
Apply computer-aided design to engineer the two arms of a bi-specifc antibody for optimal purification efficacy
This is the Partnership and Licensing section of the company profile page for Ab Studio Inc on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.